Horwitz SM - Search Results

1

Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.

Stuver R, Epstein-Peterson ZD, Horwitz SM. Stuver R, et al. Among authors: horwitz sm. Haematologica. 2023 Dec 1;108(12):3244-3260. doi: 10.3324/haematol.2023.282717. Haematologica. 2023. PMID: 38037801 Free PMC article. Review.

2

Moving towards biologically informed treatment strategies for T-cell lymphomas.

Stuver R, Lewis N, Dogan A, Horwitz SM. Stuver R, et al. Among authors: horwitz sm. Int J Hematol. 2023 Apr;117(4):492-503. doi: 10.1007/s12185-022-03524-4. Epub 2022 Dec 27. Int J Hematol. 2023. PMID: 36574170 Free PMC article. Review.

3

Correction: Moving towards biologically informed treatment strategies for T-cell lymphomas.

Stuver R, Lewis N, Dogan A, Horwitz SM. Stuver R, et al. Among authors: horwitz sm. Int J Hematol. 2023 Apr;117(4):628. doi: 10.1007/s12185-023-03565-3. Int J Hematol. 2023. PMID: 36802326 No abstract available.

4

Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions.

Stuver R, Horwitz SM, Epstein-Peterson ZD. Stuver R, et al. Among authors: horwitz sm. Curr Treat Options Oncol. 2023 Aug;24(8):948-964. doi: 10.1007/s11864-023-01111-1. Epub 2023 Jun 10. Curr Treat Options Oncol. 2023. PMID: 37300656 Review.

5

The potential for technology to aid quantitative assessment in cutaneous T cell lymphoma.

Gu L, Oh Y, Smith MP, Kurtansky NR, Horwitz S, Kahn N, Moskowitz A, Noor SJ, Myskowski P, Rotemberg V. Gu L, et al. Leuk Lymphoma. 2022 Dec;63(14):3501-3503. doi: 10.1080/10428194.2022.2131418. Epub 2022 Nov 26. Leuk Lymphoma. 2022. PMID: 36434775 No abstract available.

6

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting.

Zheng S, Gupta K, Goyal P, Nakajima R, Michaud L, Batlevi CL, Hamlin PA, Horwitz S, Kumar A, Matasar MJ, Moskowitz AJ, Moskowitz CH, Noy A, Palomba ML, Straus DJ, Von Keudell G, Falchi L, Yahalom J, Zelenetz AD, Younes A, Salles G, Schöder H, Joffe E. Zheng S, et al. Cancers (Basel). 2023 Mar 14;15(6):1760. doi: 10.3390/cancers15061760. Cancers (Basel). 2023. PMID: 36980646 Free PMC article.

7

Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach.

Vorstenbosch J, Ghione P, Plitas G, Horwitz S, Kim M, Cordeiro P, Nelson J, McCarthy C. Vorstenbosch J, et al. Ann Surg Oncol. 2024 Mar;31(3):2032-2040. doi: 10.1245/s10434-023-14636-4. Epub 2023 Dec 15. Ann Surg Oncol. 2024. PMID: 38102324

8

[No title available]

[No authors listed] [No authors listed] PMID: 38117389

9

Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure.

Buege MJ, Drill E, Horwitz SM, LeVoir A, Pak T, Peterson TJ, Dao PH, Matasar MJ. Buege MJ, et al. Among authors: horwitz sm. Eur J Haematol. 2023 Jul;111(1):96-102. doi: 10.1111/ejh.13971. Epub 2023 Apr 1. Eur J Haematol. 2023. PMID: 36971022

10

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page